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Abstract 
 
Influenza virus type A is of great concern in human, domestic and wild animal health. The 
ability of this agent of moving from one species to another confirms the “one world” concept 
of influenza or “one flu”. For this reason, the necessity of a “One Health” approach is 
required for the control and prevention of this disease. The establishment of certain 
guidelines and protocols for viral inactivation of Influenza virus would be highly advisable 
in terms of control and prevention of transmission. Ultraviolet radiation has been 
demonstrated to be an effective method to inactivate microorganisms through damage of 
their genome. This investigation wants to use the germicidal range of ultraviolet wavelength 
(UV-C) to determine the kinetic decay of influenza virus and at the same time to evaluate if 
there are any differences between four influenza type A strains from different origins (avian, 
swine and human) in terms of viral inactivation. The results showed that this method is 
effective to inactivate Influenza virus from different species. At the last time point (10 min.), 
an inactivation of approximately half of the initial concentration of viruses was observed. 
The utility of this investigation is to translate these results of inactivation to more pathogenic 
viruses of the same family or of the same genome size, especially concerning the 
management of infectious sample in BSL-3 containment. 
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1.  Introduction 
 
Over the last 20 years, public health interest has had a great deal of focus on emerging or re-
emerging infectious diseases, especially on zoonoses with a pleiotropic effect on animals, the 
environment and human health, both directly and indirectly (Brown, 2000; Ippolito & Rezza, 
2017). Influenza viruses should never be ignored when dealing with emerging disease 
problems or the possibility of an agent moving from one species to another (Brown, 2000). 
Since 2011, zoonotic influenza is one of the three priority topics of the tripartite commitment 
formed by the World Organization For Animal Health (OIE), the Food and Agriculture 
Organization of United Nation (FAO) and the World Health Organization (WHO), which 
requires the necessity of a “One Health” approach for the control and prevention of diseases 
(FAO et al., 2017).  
Influenza is a respiratory disease of humans, swine, birds, horses, mink, and some sea 
mammals caused by infection with influenza viruses of the family Orthomyxoviridae 
(Swayne, 2000). Influenza is endemic in humans, swine, horses, and some birds, but 
sporadically epidemics occur in influenza-naive populations or in the presence of the 
introduction of new subtypes (Swayne, 2000). In general, influenza viruses are adapted to a 
single host species and are transmitted freely between individuals of the same species. But, 
occasionally, influenza viruses may jump the species barrier with the capability of infecting a 
new host (Donatelli et al., 2016). Wild aquatic birds are considered the primordial genetic 
reservoir of influenza viruses (Donatelli et al., 2016). 
There are three recognized influenza virus types: A, B and C. Only type A viruses are found in 
a number of mammalian and bird species (OIE, 2015; WHO, 2018). Influenza A viruses are 
further classified into subtypes according to the presence of different surface glycoproteins 
hemagglutinin (HA) and neuraminidase (NA). At present 18 H subtypes (H1-H18) and 11 
different N subtypes (N1-N11) have been identified (Donatelli et al., 2016). Influenza type A 
viruses are of most importance to public health due their potential of transmission to humans 
and the possibility of a human to human transmission causing an influenza pandemic (WHO, 
2018). 
Depending on the original host, influenza A viruses can be classified as avian influenza “bird 
flu”, swine influenza “swine flu” with different symptomatology (WHO, 2018). In poultry, 
they can cause a severe disease with high death rate, with highly pathogenic avian influenza 
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(HPAI) subtypes, or a mid-disease with a mid-course, if the animals are infected with low 
pathogenic avian influenza (LPAI) subtypes (OIE, 2015). Avian Influenza viruses have been 
shown to cross the species barrier and infect mammalian species, most commonly swine and 
humans, with an important impact in public health. First documented case of human cross 
species transmission was during 1959 in the United States (Brown, 2000). 
Influenza A viruses are generally classed by the OIE, at least, in risk group 2 for human and 
animal infection and must be handled with appropriate biosafety and biosecurity measures. 
The potential zoonotic viruses that cause HPAI and H5/H7 LPAI belong to risk group 3-4, and 
they have the capability to spread from the laboratory if adequate levels of biocontainment 
barriers and biosafety practices are not put in place. For these subtypes, a higher level of 
biocontainment is necessary (OIE, 2015). 
Cases of laboratory workers infected from the incorrect inactivation or from mishandled 
biological samples from high pathogenic microorganisms, have been previously reported 
(Abad, 2012). A recent example was given in 2014 by the US Centers for Disease Control and 
Prevention (CDC) laboratories, when even with the high control measures of biosecurity, an 
inadvertent cross-contamination of one sample of a LPAI H9N3 virus with HPAI H5N1 was 
reported; revealing a likely departure from best practices and putting public health in a severe 
threat (CDC, 2014). The development of new strategies to increase biosecurity is extremely 
necessary. The establishment of certain guidelines and protocols for viral inactivation with a 
good studied efficacy, and the creation of a bank of potential viruses to be tested, would be 
highly advisable (Abad, 2012). 
Inactivation through chemical, heat and radiation procedures are currently used to remove 
infectious and suspicious samples from these biocontainment units (Shurtleff et al., 2012). UV 
treatment has its most common use in laboratories in biological safety cabinets as a typical 
procedure to disinfect the working surface, after using the cabinet. In biosafety level 3 
laboratories (BSL-3), UV treatment is also often used for passing out of the laboratory 
potentially contaminated materials through pass boxes in ultraviolet bathed portals (Turnbull 
et al., 2008). 
 
It has been demonstrated that microorganisms exposed to UV light prove an exponential 
decrease in population similar to other inactivation methods (Cutler & Zimmerman, 2011; 
Kowalski et al., 2000). Ultraviolet light is a portion of the electromagnetic spectrum with the 
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wavelength range of 100-400 nm. This wavelength range is generally divided into four bands 
based on the interaction with the molecules: UV-A (320-400 nm), UV-B (320-280 nm), UV-C 
(200-280 nm) and the vacuum UV (100-200 nm) (Sastry et al., 2000; Yin et al., 2013). The 
UV-C band is also known as the germicidal part of the UV light, for the capability of this 
wavelength of being absorbed by nucleic acids, with the highest effect achieved using 254 nm 
(Cutler & Zimmerman, 2011). Unsaturated organic compounds of the nucleic acid have the 
capability to absorb wavelengths between 200 and 280 nm. The principal unsaturated organic 
compounds in cells are pyrimidines, purines and flavins, essential for reproduction and 
metabolism (Cutler & Zimmerman, 2011). This absorption by the nucleic acids leads to the 
formation of photoproducts, most common pyrimidine dimers, that block the DNA or RNA 
transcription and replication compromising the normal function of the cells leading to cell 
death (Cutler & Zimmerman, 2011; Sastry et al., 2000).  
The first experimental studies of the inactivation effects with UV254 were conducted to 
attempt to control airborne spread of microbial infections. The first reported study of the effect 
of UV-C treatment on influenza viruses was carried out by Jensen in 1964. Since then, several 
studies were carried out about UV-C sensitivity of various microorganisms including parasites 
(Chang et al., 1985), spores and fungi (Green et al., 2004) and it has been shown that viruses 
are the most resistant organisms to Monochromatic (MC) UV254 nm radiation, especially 
those from the Adenoviridae family, followed by bacterial spores and the Acanthamoeba spp. 
protozoa (Chang et al., 1985; Hijnen et al., 2006). The highest UV sensitivity in a virus with 
veterinary importance was shown for bovine, canine and feline Caliciviruses and for human 
health, for Hepatitis A virus (Hijnen et al., 2006). 
Concerning viruses, studying the inactivation kinetics of different types, it was demonstrated 
that the inactivation by UV-C light depends basically on the genome size of the virus and the 
type of genome (DNA-RNA, ss-ds) would be of secondary importance (Schmidt & Kauling, 
2007;Thurston-Enriquez et al., 2003). Regarding the medium in exam, higher susceptibility in 
viral aerosol than in viral liquid suspension was observed (Walker & Ko, 2007).  
Influenza A are negative-sense, single stranded segmented RNA (8 segments – 13.6 kb) 
viruses (Swayne, 2000; Donatelli et al., 2016); they are prone to change genetically with 
antigenic drift and antigenic shift, with a high mutation rate (Donatelli et al., 2016). This 
characteristic enables the virus to evolve from a LPAIV to a HPAIV form and to continually 
be highly variable, increasing the difficulty to prevent events increasing the risk for human 
health (EFSA, 2005). Moreover, that HPAI viruses arise from LPAI viruses through mutation 
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has been phylogenetically studied (Banks et al., 2000; Röhm et al., 1995), this is one of the 
reasons why they share similar physical and chemical characteristics (Thomas & Swayne, 
2007).  
The intention of this investigation is to profit of the similarities between this virus type, 
assaying four different influenza type A viruses with low pathogenicity as a surrogate to 
extrapolate as a possible information to HPAI virus characteristics of sensitivity to UV-C 
exposure inactivation. 
 
2. Objective 
The objective of this study was to determine the efficacy and kinetics of inactivation, of four 
different Influenza A virus isolated from different species (avian, swine and human), using 
UV-C  (254 nm).  
 
3. Materials and Methods 
 
3.1. Viruses 
Four different viral strains were used in the present study. Two strains were from avian-origin: 
A/Duck/Italy /281904/06 H1N1 (named avH1N1) and A/Mallard/Italy /239453/05 H4N6 
(named avH4N6), both from the Istituto Zooprofilattico Sperimentale della Lombardia e 
dell’Emilia Romagna (Italy). One swine strain A/Swine/Spain/SF11131/2007 H1N1 (named 
swH1N1) from the CReSA virus repository and a one human-origin IAV strain A/Catalonia 
/NSVH 10076691/2018 Pandemic H1N1 (named huH1N1) from Hospital de la Vall d’Hebron 
(Barcelona).  
3.2. Virus propagation in embryonated Specific-Pathogen-Free (SPF) eggs 
Virus stocks were produced in 11 day-old SPF eggs. Several dilutions from the original 
inoculum were used: 10-1, 10-2, 10-3 for avH1N1 and huH1N1 and 10-1, 10-2, swH1N1 and 
avH4N6, respectively. For each dilution, 5 eggs were used and 5 negative controls were also 
included.  
The eggs with the air space up were placed inside a biological safety cabinet. The eggshell of 
each egg above the air space was disinfected with 70% ethanol. A sterile 18G needle was used 
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to punch a small hole in the shell; volumes of 0.1 ml of each of the diluted influenza virus 
suspensions were injected (carefully in a vertical position) into the allantoic cavity using a 
25G needle insulin syringe. The hole was sealed with a drop of glue. After inoculation the 
eggs were placed back into the egg incubator with the air space pointed upwards and without 
turning. 
At 24 hours p.i., eggs were candled and all eggs were viable. Briefly, after an incubation 
period of 72 hours, the eggs were chilled at -20 ºC for 20 minutes to kill the embryos. The 
eggs in an egg holder with the air sac facing up were transferred to a biological safety cabinet. 
The egg surface was cleaned with 70% ethanol. Sterile scissors were used to open the eggshell 
above the air sac, being careful not to leave traces of shell and not to destroy the 
chorioallantoic membrane. The chorioallantoic membrane was exposed with sterile blunt 
forceps and the sterile scissors. The embryo and the yolk sac were gently moved aside with a 
small spatula, taking care not to rupture the yolk. Using a Pasteur pipette, the allantoic fluid 
was collected. The allantoic fluids from the eggs spiked with same dilution of a virus were 
combined into a 50 ml sterile conical tubes. The different collection of the allantoic fluid was 
based on the time of death of the embryo and the dilution. Collection 50 ml tubes were keep 
on ice at all times during virus harvest. Once the harvest off the fluid from all of the eggs was 
done they were left to decant at 4 ºC. After then, they were centrifuged to pellet debris. The 
clear fluid from each virus harvest and from negative samples, was transferred into new 50 ml 
conical tubes kept on ice and 150 μl of each were aliquoted in sterile eppendorf microtubes. 
The 50 ml tubes and eppendorf microtubes were both frozen in a -75 °C ultra-freezer for long-
term storage. Eggs were properly disposed into a BSL-2 group III waste container. 
 
3.3. Viral detection by quantitative Real-Time Polymerase chain reaction (qRT-PCR) 
In order to rapidly assess the viral loads of the different propagated viruses, a qRT-PCR was 
done with the allantoic fluids. Viral RNA was extracted using NucleoSpin® RNA Virus kit 
(Macherey-Nagel, Düren, Germany) following the manufacturer’s instructions. Negative and 
positive controls were added in each extraction batch. 
A qRT-PCR to detect and quantify influenza type A virus was used using protocol already 
described that targets the M gene of influenza A virus (Busquets et al., 2010). Briefly, qRT-
PCR reagent mix was prepared in laminar flow hood: in one eppendorf tube 0.8 μl of “RT-
PCR Enzyme Mix 25x”, 1 μl of “Probe +64 (6 μM) (Fam-Tamra)”, 10 μl of “RT-PCR Buffer 
2x”, 0.8 μl of “Primer +25 (10 μM)”, 0.8 μl of “Primer -124 (10 μM)”, 1.37 μl of “Internal 
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Positive Control (IPC)” and 2.23 μl of “H20 Rnase Free” were added vortexing between each 
addition. A 96 well plate was prepared in a laminar flow hood, each well was numbered and 
filled up with 17 μl of the RT-PCR mix (previously calculated). A volume of 3 μl of each 
RNA sample (previously numbered on the extraction sheet) was subsequently added to each 
well, resulting in 20 μl for each well. The plate was sealed with PARAFILM® M Sealing Film 
(Merck KGaA, Darmstadt, Germany), very carefully to avoid contamination during the RT-
PCR. Later, the plate was spun to homogenize the content of each well, by slow 
centrifugation, to eliminate the bubbles that might exist between both solutions. The plate was 
placed in the RT-PCR Applied Biosystems 7500 Fast Instrument. Using the “7500 software v. 
2.3”, each well was named and numbered according to the samples and specific conditions 
(cycles, duration and temperature) were chosen before the start. The routine consisted in 
several steps: 48 °C - 10 minutes; 95 °C - 10 minutes; 40x (97 °C - 2 seconds; 61 °C - 30 
seconds). Positive and negative controls were added to each batch of samples. Results were 
expressed as Ct values. 
Allantoic fluids inoculated with the same viruses were pooled. For this process, 3 different 
filters were used in the following sequence: 0.8 μm filter (FP 30/0.2), the 0.45 μm filter (FP 
30/0.45) and lastly 0.2 μm filter (FP 30/0.8). The resulting liquid from each virus was 
collected using a 5 ml syringe and transferred to 50 ml Falcon tubes, and 150 μl were 
aliquoted in sterile eppendorf tubes (one for each virus). The obtained 50 ml tubes were frozen 
in a -75 °C ultra-freezer for long-term storage and the eppendorf tubes were used for the 
second RNA Extraction. 
 
3.4. Experimental design of viral inactivation by UV exposure  
A homogeneous volume of each virus strain was pipetted in a six well sterile cell culture plate 
(SPL Cell Culture Plate). The plate was exposed to a 254 nm UV Lamp and a power of 8W 
(Vilber Lourmat® 4.C) fixed at a height of 10 cm to the liquid layer to be inactivated. At 0 
seconds, 30 seconds, 2 minutes, 5 minutes and 10 minutes, 100 μl of the irradiated viral 
suspension were withdrawn. At the last time point (10 minutes) all of the remaining volume 
was collected. This procedure was repeated twice for each virus strain, except for the 0 time 
point that was used for both repetitions. The obtained samples were kept in the -75 ºC ultra-
freezer until further titration. 
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3.5. Titration in MDCK (Madin-Darby canine kidney) cells 
MDCK cells were prepared in 96 well plates (SPL Life sciences Tissue Culture Test Plate) 24 
or 48 hours before titration, following internal standard protocols. Briefly, cell monolayer was 
separated by the action of trypsin, and cells were suspended in 10% fetal bovine serum culture 
media to achieve a final concentration of 2 x 10-6 cells / ml. This solution was homogenized 
by gentle pipetting and then mixed with BioWhittaker® Dulbecco’s Modified Eagle’s 
Medium (DMEM) (Mediatech Inc., Manassas, VA, USA) supplemented with 2 mM L-
Glutamine and 100 UI/100 ug/ml of Penicillin + Streptomycin. To seed the microplates 100 μl 
of the aforementioned cell suspension was spiked in each well. Each plate was fully identified 
and incubated in a HERA cell CO2 incubator at 37.0 ± 1.5 ºC. After 24 or 48 hours, the cell 
growth was checked with the Nikon Eclipse T5100 inverted microscope to see if confluent 
monolayers were achieved; titration was only performed if this criteria was met. Before 
titration, plates were washed for at least 10 minutes with PBS.   
Initial inoculum as well as UV-treated samples at the different time points (0 seconds, 30 
seconds, 2 minutes, 5 minutes and 10 minutes) were taken from the -75 ºC ultra-freezer and 
were left to defrost at room temperature inside a BCS. Microtubes containing 450 μl of sterile 
PBS supplemented with 10 μg/ml trypsin from porcine pancreas type IX (Sigma Chemical 
Co., St Louis, MO, USA) were prepared. Dilutions of samples for titration were done (from 
10-1 to 10-6, depending on the on-going results) and incubated in the cell CO2 incubator at 37.0 
± 1.5 ºC for 30 minutes, for the trypsin to enhance virus infection. To proceed to titrate each 
sample, 20 μl of the previously prepared dilution, were inoculated at each well (from the most 
diluted to the original sample). The plates were left to incubate in a CO2 incubator at 37ºC for 
60 minutes. After incubation, 150 μl of p.i. media DMEM Lonza supplemented with 
Glutamine and Penicillin+Streptomycin and containing 1 μg/ml of trypsin from porcine 
pancreas type IX (Sigma Chemical Co., St Louis, MO, USA) was also added to each well. The 
plates were incubated in the CO2 incubator at 37 ± 1.5 ºC for no more than 10 days p.i.  
As a current schedule, the first reading of microplates was done 5 days and the final reading at 
7 days p.i. A Nikon inverted microscope was used at a 40x magnification to read the 
cytopathic effect (CPE) on the cells. The results were recorded and the log10 TCID50 was 
calculated following the formula shown below: 
 
log10 TCID50 = 1r+ 1/2d - d Σ pi 
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Where: 
1r = logarithm of the highest dilution that has 100% cytopathic effect, this means, destruction 
of all of the replicas. 
d = logarithm of the dilution ratio (in decimal dilutions it will always be 1) 
pi = positive response to dilution “i”. 
This equation was applicable when throughout the dilution series we find a range of infectivity 
from 100% to 0%. When there was no 0% associated to the dilution, the next dilution was 
given the value of 0%. 
 
4. Results 
 
4.1. Influenza virus propagation in SPF chicken eggs 
All viruses replicated in SPF eggs. Egg mortality varied among the different viruses and 
dilutions. It was higher in eggs inoculated with higher dilutions of avH1N1 and avH4N6 
(Table 1). At 48 hours p.i. , eggs were candled and 2 eggs were not viable, one from avH1N1 
at 10-3 dilution and one from swH1N1 at 10-1. In the case of huH1N1, 2 eggs of each dilution 
were left until 96 hours, they were still viable after this time. In general, a volume of 5-7 ml of 
a slightly yellowish allantoic fluid was obtained from each egg.  
 
                                 Viruses 
Dilution avH1N1 avH4N6 swH1N1 huH1N1 
10-1 80% 100% 50% 0% 
10-2 60% 50% 80% 0% 
10-3 50% nd nd 0% 
Table 1. Accumulated mortality of embryonated SPF eggs observed with different dilutions of each viral strain. 
eggs. nd: not determined. 
 
Regarding viral loads, no major differences were observed in the different dilutions and at 
different hours p.i. for each viral strain, neither between viable and non-viable eggs. 
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Differences in viral loads were observed when comparing the different viral strains (Table 2). 
The results of qRT-PCR were expressed as Threshold Cycle (Ct) values used to identify the 
amounts of target nucleic acid. Lower Ct values indicate high amounts of the target RNA 
while higher Ct values mean lower amounts of target RNA. 
 
                                                                                          Viruses 
Dilution avH1N1 avH4N6 swH1N1 huH1N1 
10-1 15 20 18.5 28 
10-2 15 19 18 24.5 
10-3 15 nd nd 28 
Table 2. Means of Ct values from viable and non-viable inoculated SPF eggs at different hours p.i.  nd: not 
determined. 
 
Finally, viral loads (Ct) for each virus strain pool to be used in the inactivation study were: 
avH1N1= 16; avH4N6= 22; swH1N1= 20; and huH1N1= 31. 
 
4.2. Inactivation kinetics 
All viruses were able to infect the confluent monolayer MDCK cells in the presence of 
trypsin, with significantly different capacities. AvH1N1 and swH1N1 and avH4N6 infection 
caused a complete MDCK cell monolayer destruction; instead, huH1N1 pandemic virus 
infection produced only small foci of infected cells. The first titration of each virus was done 
with the aliquot of the frozen samples to calculate the starting log10 TCID50. No remarkable 
differences in terms of viral titre were observed among the four different influenza virus, with 
a range of means from 5.5 土 0.7 (avH4N6) to 6.8 土 0.3 (avH1N1) (Table 3). 
 
 
                                 Viruses 
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 avH1N1 avH4N6 swH1N1 huH1N1 
Titration 7.0 土 0.3; 6.6 土 0.4 
5.0 土 0.3; 
6.0 土 0.4 
6.2 土 0.7; 
5.6 土 0.5 
6.3 土 0.6; 
5.8 土 0.6 
Mean 6.8 土 0.3 5.5 土 0.7 5.9 土0.4 6.1 土 0.4 
 
Table 3. log10  TCID50 per ml values of Avian-Pandemic-Swine H1N1 and avH4N6 viruses in initial titration. 
 
Detection limit was established considering the dilution without any positive wells in a range 
between 0 and 1.8 log10 TCID50. Value of 1.8 was calculated considering the inoculated 
volume for each wells respect 1 ml. Thus, in this study, the limit of detection for the microtitre 
plate assay was 1.8 log10 TCID50. For statistical and data analysis the working value was 1.8 
considering the worst effect of the treatment at this situation.  
The Residual Factor (RF) values were calculated to reveal the difference between the starting 
dose at time 0 from the calculated dose at each time point. All the inactivation kinetics reveal 
a decreasing in log10 TCID50 , shown by the RF values that increase proportionally to the time of 
exposure (Table 4). The most sensitive viruses to the UV-C treatment were swH1N1 and 
huH1N1. They started to be sensitive yet after 30 sec of exposure; and also at the last point 
time (10 min.) they showed a major value of RF, representing a loss of more of the half initial 
concentration of each virus. 
  RF 30 sec. 2 min. 5 min. 10 min. 
avH1N1 0.1 0 2.3 2.6 
avH4N6 0 1.4 2.6 2.6 
swH1N1 1.3 1.7 3.3 3.2 
huH1N1 1.0 2.0 2.7 3.5 
Table 4. Reduction factor (RF) values sorted in relation between viruses and time of exposure. 
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The linear regressions showed that the general tendency of the variable of the mean and the 
time of each experiment were in an inverse correlation as shown on Figures 1 to 5. Negative 
results of the slope of the linear regression were clearly shown by each inactivation kinetics 
graph of each virus. This is numerically reported with their negative slope values: -0.0049 for 
avH1N1; -0.046 for avH4N6 virus; -0.047 for swH1N1; and -0.0051 for huH1N1. Other 
calculated data of the linear regression were the coefficient of determination “R2” and the 
intercept value. The R2 calculated values were: 0.84 for avH1N1; 0.76 for avH4N6; 0.72 for 
swH1N1; and 0.84 huH1N1. Estimated intercept values were: 5 for avH1N1; 4.7 for avH4N6; 
4.4 for swH1N1; and 4.8 for huH1N1 (Fig.1 to 5).  
To complete the comparison of the different effects of UV radiation between viruses, a 
Kruskal-Wallis test was effectuated using the slope values. The selected alpha value was of 
0.05 and the resulting p-value was 0.39, so there were no statistically significant differences 
among the viruses. 
 
 
Figure 1. avH1N1 virus: Kinetic and linear regression of log10 TCID50 per ml values at different times of 
exposure. 
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Figure 2. swH1N1 virus: Kinetic and linear regression of log10 TCID50 per ml values at different time of exposure. 
 
 
Figure 3. huH1N1 virus: kinetic and linear regression of log10 TCID50 per ml values at different times of exposure. 
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Figure 4. avH4N6 virus: kinetic and linear regression of log10 TCID50 per ml values at different times of exposure. 
 
Figure 5. Comparison between the linear regression of each virus. 
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6. Discussion 
 
When working with highly pathogenic influenza viruses in biocontainment facilities, one of 
the main challenges is the inactivation of samples for further studies in biocontainment or 
out of biocontainment. To do so, several systems are available, some are physical and others 
chemical. The choice among them will be driven by the final destination of the sample. For 
immunological studies, the target should be the nucleic acid, allowing proteins to keep these 
natural conformations while for molecular biology studies (as PCRs) the target will be the 
proteins and lipid envelopes. In both cases, it should be assessed if all these processes are 
able to completely inactivate infectivity from the samples as they will be handled in less 
stringent biosafety conditions (X. Abad, personal communication, July 2, 2018). 
As UV treatment acts on nucleic acids, it has been used thoroughly in research centres as a 
way to inactivate viral suspensions keeping immunological properties intact (Schmidt & 
Kauling, 2007; Turnbull et al., 2008). However, when working with highly pathogenic 
viruses, in BSL-3 containment, the need to assure that this procedure gives completely 
inactivated viral suspensions is more evident, taking into account that sometimes such 
inactivations are done to transfer the samples outside for further processing (Abad, 2012). 
The establishment of certain guidelines and protocols for viral inactivation with good and 
reliable efficacy studies, and the creation of a bank of potential viruses to be tested, would be 
highly advisable (Abad, 2012).  
For biological, sanitary and economic reasons, studying the most pathogenic viruses directly, 
is not always possible. Therefore, taking into account the similarities of biological and 
physical characteristics of viruses, it is useful to work in parallel using similar, less 
pathogenic viruses as surrogates. This is a common practice used in laboratories as showed 
by the studies of  Steinmann (2004), Casanova & Weaver (2015) and Takada & co-workers 
(1999). 
In our study, we have worked with four different influenza viruses isolated from the three 
main hosts of these viruses: birds, pigs and humans. This gives a more “One health” 
approach to the study and at the same time tries to cope with viral diversity.  
The results on initial viral replication and viral loads in our study showed many differences, 
especially between avian and human pandemic virus. This event could have occurred 
because of the facility of the virus to replicate in the same species of provenience of the 
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cells. Furthermore, the different CPE in MDCK cells could suggest that pandemic viruses 
possesses limitations in this cell line, with no particular predilection for this cell line to 
replicate. This characteristic of different tropism of pandemic influenza viruses has been 
previously described (Ilyushina et al., 2012). 
There are not many available studies specifically focused on resistance of Influenza A 
viruses to UV-C rays. Moreover, in most of these studies, the results are based on the “UV 
dose (mJ/cm²)” that represents the intensity or potency of the lamp on the sample for a given 
time (Cutler et al., 2011; Jensen, 1964). Indeed, the results are shown as rate of inactivation, 
named “k”, which is calculated based on the “UV dose”. The rate of inactivation is sensitive 
to numerous secondary factors, such as: type of microorganism, composition of suspending 
medium, temperature, humidity and depth of the irradiated solution (Cutler et al., 2011; 
Jensen, 1964; Kowalski et al., 2000). Unfortunately, in the present experiment the evaluation 
of the intensity value of the lamp during the inactivation trial was not possible, making it 
difficult to compare the numerical results.  
Regarding the exposure to ultraviolet light in our work, all viruses showed an inverse 
correlation between the infectivity values (expressed as mean of  log10 TCD50 of survival 
viruses) and exposure times, as it is demonstrated with the negative slope values from 0 to -1 
of the linear regressions. So, any increase in the UV-C irradiation time corresponds to a 
decrease of viral infectivity, obtaining at the last time point (10min.) an inactivation of 
approximately more of half of the initial doses of the viruses. This is a typical representation 
of an inactivation model of many other germicidal methods (Cutler & Zimmerman, 2011; 
Kowalski et al., 2000), confirming the lethal effect of the UV-C on the viruses (Cutler et al., 
2011; Harris et al., 1987; Jensen, 1964; Schmidt & Kauling, 2007). 
The inactivation model was first studied by Hiatt (1964)  that described the rapidity of decay 
by the rate of inactivation “k” which expresses algebraically the relationship between 
concentration and time. This model was called the first order one-stage model and its 
principal limitation was that it considered the sample as a homogenous sample. Later on, 
other authors observed that many inactivation reactions did not follow this one-stage model, 
probably due to the fact that not all samples are homogeneous or for other reasons. Based on 
this, a two-stage inactivation model with two different phases with respectively different 
rates of inactivation was proposed (Cutler et al., 2011; Thurston-Enriquez et al., 2003). 
Nevertheless, the two-stage approach has not been widely used to describe the kinetics of 
microbial inactivation and most of the studies still base the results on the one stage model 
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(Cutler et al., 2011). A clear example of the limitation of the one-stage model is given by 
what we found in our results. In the initial inactivation, 3 out of 4 viruses showed around 2 
log10 inactivation at 2 minutes of UV-C treatment with best values of RF for swH1N1 
and  huH1N1. Following this linear process it would be expected that at 10 minutes the 
treatment would be able to totally inactivate the infectivity of the assayed viruses (as their 
viral titers slightly surpass 6 log10 TCID50). However, for 4 out of 4 assayed viruses residual 
infectivity was detected in final samples, a bit major of the detection limit value (≼1,8). 
Moreover, the measure of goodness of the linear regression was important to perform by the 
evaluation of R2 values, for each kinetic decay equation. Best values were calculated for 
avH1N1 and huH1N1 kinetics, for these viruses we can affirm that the one-stage inactivation 
model is more representative respect to swH1N1 and avH4N6 viruses in which a two stages 
model decay could be supposed. So, we can conclude that generally in influenza A viruses, 
the one-phase model does not fit perfectly to the calculated data of doses. This evaluation 
strengthens Cutler's theories of inactivation studied with only one strain of influenza virus.  
The difference in velocity of decay observed among the four different viruses is a common 
problem in kinetics of inactivation studies effectuated with UV-C treatment. This event 
could be related to the fact that a homogenous sample was not used and also to the 
possibility of clumping, dormancy or other factors (Thurston-Enriquez et al., 2003; 
Kowalski et al., 2000). 
The results of the Kruskal-Wallis test give us two important pieces of information to take 
into consideration. One is the fact that there are not differences between the response of each 
virus to the UV-C treatment, confirming the theory that though from different origins, they 
maintain similar biological and physical characteristics (Thomas & Swayne, 2007). 
Secondly, is that we could combine the results of each virus as a single result, obtaining a 
generic result for inactivation response for a generic influenza type A virus. This data could 
also contribute to adding more information in the response to physical treatment with UV-C 
rays, extending the results to the viruses with the same genetic characteristics (ss-RNA and 
13.6 kb).  
Finally, we can conclude that the inactivation treatment tested in this laboratory conditions 
was not able to inactivate the totality of the viruses in the samples. Although viral infectivity 
was clearly diminished, infectious viruses still remain in the samples. So, we can conclude 
that further assays should be performed, increasing exposure time, to ensure that such viral 
suspensions are really safe to be handled in lower biosafety levels. 
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7. Conclusions 
 
With this study of the inactivation of four different Influenza A type viruses at five different 
time points, we can conclude that: 
● The inactivation treatment with UV-C (254 nm) is germicidal for the four influenza 
viruses tested (AvH1N1, avH4N6, swH1N1 and huH1N1).  
● The inactivation kinetics of the treatment with UV-C (254 nm) does not differ among 
the four influenza viruses used in the present study and follows a first-order reduction 
tendency, with differences in one or two-stage reduction.  
● The inactivation treatment with UV-C (254 nm) was not able to totally inactivate the 
viruses in the samples after 10 minutes of exposure. 
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8. Anexos 
 
 
 
 
 avH1N1  0 30 sec 2 min 5 min 10 min 
Exp. I 6.2 土  0.0; 
 6.8 土  0.3 
4.3 土 0.3 
 
5.5 土 0.3;     
5.7 土 0.4 
3.1 土 0.2; 
2.7 土 0.4 
 2.3 土 0.3; 
 3.2 土 0.0 
Exp.  II 3.7 土 0.4; 
3.3 土 0.2 
5.5 土 0.3; 
5.0 土 0.3 
4.9 土 0.4;  
4.2 土 0.5 
2.6 土 0.4; 
2.5 土 0.3 
2.3 土 0.3; 
1.8 
Mean  I 6.5 土 0.4 4.3 土 0.3 5.6 土 0.1 2.9 土 0.3 2.8 土 0.6 
Mean  II 3.5 土 0.3 5.3 土 0.5 4.6 土 0.5 2.6 土 0.1 2.1 土 0.4 
Total Mean 5.0 土 2.7 4.9 土 0.9 5.0 土 0.9 2.7 土 0.4 2.4 土 0.9 
 
Table 4. Single and mean values of log10 TCID50 per ml of  avH1N1 virus inactivation treatment. Classification sorted 
by titration, time of exposure. 
 
 
 
 
 
 swH1N1 0 30 sec 2 min 5 min 10 min 
Exp. I 5.3 土 0.2; 
5.2 土 0.3 
3.5 土 0.3;  
4.3 土 0.2 
3.2 土 0.5; 
3.2 土 0.0 
1.8; 
1.8 
2.3 土 0.3; 
1.8 
Exp.  II 5.3 土 0.5 
 
3.6 土 0.4;  
4.6 土 0.4 
3.8 土 0.4; 
 4.0 土 0.3 
1.8; 
2.7 土 0.4 
2.3 土 0.3; 
1.8 
Mean I 5.3 土 0.1 4 土 0.6 3.2 土 0 1.8 2.1 土 0.3 
Mean II 5.3 土 0.0 4.1 土 0.7 3.9 土 0.4 2.3 土 0.6 2.1 土 0.3 
Total Mean 5.3 土 0.1 4.0 土 0.8 3.6 土 0.6 2.0 土 0.6 2.1 土 0.5 
 
Table 6. Single and mean values of log10TCID50 per ml of swH1N1 virus inactivation treatment. Classification sorted by 
titration, time of exposure. RF value calculated for each time of exposure.  
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huH1N1 0 30 sec 2 min 5 min 10 min 
Exp. I 5.8 土 0.4; 
6.0 土 0.5 
5.0 土 0.4; 
5.1 土 0.5 
3.8 土 0.4; 
3.8 土 0.4 
3.1 土 0.5; 
3.1 土 0.5 
2.5 土 0.3; 
2.3 土 0.3 
Exp.  II 5.5 土 0.5; 
5.1 土 0.5 
4.2 土 0.5; 
4.2 土 0.5 
3.7 土 0.4; 
3.2 土 0.0  
2.7 土 0.4; 
2.5 土 0.3  
1.8; 
1.8 
Mean I 5.9 土 0.1 5.1 土 0.1 3.8 土 0.0 3.1 土 0.0 2.4 土 0.1 
Mean II 5.3 土 0.3 4.2 土 0.0 3.5 土 0.4 2.6 土 0.1 1.8 土 0.0 
Total Mean 5.6 土 0.5 4.6 土 0.8 3.6 土 0.4 2.9 土 0.4 2.1 土 0.6 
Table 5. Single and mean values of  log10TCID50 per ml of huH1N1 virus. Classification sorted by titration, time of 
exposure.  
 
 
 
 
 
avH4N6 0 30 sec 2 min 5min 10min 
Exp. I 5.2; 
5.2 土 0.6 
5.2 土 0.5; 
5.0 土 0.4 
3.6 土 0.4; 
3.5 土 0.3 
2.5 土 0.3; 
2.5 土 0.3 
2.3 土 0.5; 
2.5 土 0.3 
  
Exp.  II 5.1 土 0.4; 
4.8 土 0.4 
5.0 土 0.4; 
5.2 土 0.5 
3.8 土 0.4; 
3.8 土 0.4 
2.6 土 0.4; 
2.5 土 0.3 
2.5 土 0.3; 
2.5 土 0.3  
Mean  I 5.2 土 0.0 5.1 土 0.1 3.6 土 0.1 2.5 土 0.0 2.4 土 0.1 
Mean II 5.0 土 0.2 5.1 土 0.1 3.8 土 0.0 2.6 土  0.1 2.5 土 0.0 
Total Mean 5.1 土 0.2 5.1 土 0.2 3.7 土 0.2 2.5 土  0.1 2.5 土 0.2 
Table 7. Single and mean values of log10TCID50 per ml of avH4N6 virus. Classification sorted by titration, time of 
exposure.  
 
